Mechanistic insights into the direct antioxidant effects of estrogens

Drug Development Research

Volumn 66, Issue 2, 2005, Pages 118-125

  Prokai, Laszlo ^a,b   Prokai Tatrai, Katalin ^b   Perjési, Pál ^c   Simpkins, James W ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Antioxidant; Estrogen; Free radical scavenging; Neuroprotection; Reactive oxygen species

Indexed keywords

17ALPHA ESTRADIOL; ALPHA TOCOPHEROL; ANTIOXIDANT; ESTRADIOL; ESTRIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE; FREE RADICAL; PHENOL DERIVATIVE; PRODRUG; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ANTIOXIDANT ACTIVITY; CELL PROTECTION; DRUG MECHANISM; LIPID PEROXIDATION; MACROMOLECULE; MICROENVIRONMENT; NEUROPROTECTION; OXIDATIVE STRESS; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 33644842324     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20050     Document Type: Review

References (88)

1. Albert A. 1958. A chemical aspect of selective toxicity. Nature 182: 421-423.
2. Artega E, Rojas A, Villaseca P, Bianchi M. 2000. The effect of 17β-estradiol and α-tocopherol on the oxidation of LDL cholesterol from postmenopausal women and the minor effect of gamma-tocopherol and melatonin. Menopause 7:112-116.
3. Beckman KB, Ames BN. 1998. The free radical theory of aging matures. Physiol Rev 78:547-581.
4. Behl C. 1999. Alzheimers disease and oxidative stress: implications for novel therapeutic approaches. Prog Neurobiol 57:301-323.
5. Behl C, Davis J, Cole GM, Schubert D. 1992. Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem Biophys Res Commun 186:944-950.
6. Bergamini CM, Gambetti S, Dondi A, Cervellati C. 2004. Oxygen, reactive oxygen species and tissue damage. Curr Pharmaceut Des 10:1611-1626.
7. Berkowitz J, Ellison GB, Gutman D. 1994. Three methods to measure RH bond energies. J Phys Chem 98:2744-2765.
8. Bishop GM, Robinson SR. 2001. Quantitative analysis of cell death and ferritin expression in response to cortical iron: implications for hypoxia-ischemia and stroke. Brain Res 90:175-187.
9. Borras C, Gambini J, Gomez-Cabrera MC, Sastre J, Pallardo FV, Mann GE, Vina J. 2005. 17β-Oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFκB cascade. Aging Cell 4:113-118.
10. Brozmanova J, Dudas A, Henriques JAP. 2001. Repair of oxidative DNA damage: an important factor reducing cancer risk. Minireview. Neoplasma 48:85-93.
11. Bush AJ. 2000. Metals and neuroscience. Curr Opin Chem Biol 4:184-191.
12. Campbell A, Smith MA, Sayre LM, Bondy SC, Perry G. 2001. Mechanism by which metals promote events connected to neurodegenerative diseases. Brain Res Bull 55:125-132.
13. Courderot-Masuyer C, Lahet JJ, Verges B, Brun JM, Rochette L. 2000. Ascorbic free radical release in diabetic patients. Cell Mol Biol 46:1397-1401.
14. Denisov ET, Denisova TG. 2000. Handbook of antioxidants: bond dissociation energies, rate constants, activation energies, and enthalphies of reactions, 2nd ed. Boca Raton, FL: CRC Press. 289p.
15. Dunford HB. 1995. One-electron oxidations by peroxidases. Xenobiotica 25:725-733.
16. Ettmayer P, Amidon GL, Clement B, Testa B. 2004. Lessons learned from marketed and investigational prodrugs. J Med Chem 47: 2393-2404.
17. Finkelshtein EI. 2001. Radical stabilization energy as a measure of the spectral properties and reactivity trends in homologous groups. J Phys Org Chem 4:543-550.
18. Frei B, Stocker R, Ames BM. 1992. Small molecule antioxidant defenses in human extracellular fluids. In: Scandalios JG, editor. Current communications in cell and molecular biology, Vol. 5. Molecular biology of free radical scavenging systems. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. p 23-45.
19. Fujisawa S, Kadoma Y. 2004. Kinetic studies of the radical-scavenging activity of estrogens and antiestrogens. Anticancer Res 24:3931-3937.
20. Ganong WF. 1999. Review of medical physiology, 19th ed. Stamford, CT: Apple and Lange. 419p.
21. Garner B, Davies MJ, Truscott RJ. 2000. Formation of hydroxyl radicals in the human lens is related to the severity of nuclear cataract. Exp Eye Res 70:81-88.
22. Goeptar AR, Scheerens H, Vermeulen NP 1995. Oxygen and xenobiotic reductase activities of cytochrome P450. Crit Rev Toxicol 25:25-65.
23. Gomez-Zubeldia MA, Arbues JJ, Hinchando G, Nogales AG, Millan LC. 2001. Influence of estrogen replacement therapy on plasma lipid peroxidation. Menopause 8:274-280.
24. Gotz ME, Kunig G, Riederer P, Youdim MBH. 1994. Oxidative stress: Free radical production in neural degeneration. Pharmacol Ther 63:37-122.
25. Green PS, Gordon K, Simpkins JW. 1997. Phenolic A ring requirement for neuroprotective effects of steroids. J Steroid Biochem Mol Biol 63:229-235.
26. Green PS, Gridley KE, Simpkins JW. 1998. Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione. Neuroscience 84:7-10.
27. Gridley KE, Green PS, Simpkins JW. 1998. A novel, synergistic interaction between 17 beta-estradiol and glutathione in the protection of neurons against beta-amyloid 25-35-induced toxicity in vitro. Mol Pharmacol 54:874-880.
28. Hall ED, Pazara KE, Linseman KL. 1991. Sex differences in post-ischemic neuronal necrosis in gerbils. J Cereb Blood Flow Metab 11:292-298.
29. Halliwell B. 1992. Reactive oxygen species and the central nervous system. J Neurochem 56:1609-1623.
30. Halliwell B, Aruoma OL 1991. DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett 281:9-19.
31. Halliwell B, Gutteridge JMC. 1999. Free radicals in biology and medicine, 3rd ed. Oxford, UK: Oxford University Press. p 105-245.
32. Hunter EPI, Desrosiers MF, Simic MG. 1989. The effect of oxygen, antioxidants and superoxide radical on thyrosine phenoxyl radical dimerisation. Free Rad Biol Med 6:581-585.
33. Inder TE, Volpe JJ. 2000. Mechanisms of perinatal brain injury. Semin Neonatal 5:3-16.
34. Kohar I, Baca M, Suarna C, Stocker, R, Southwell-Keely P. 1995. Is α-tocopherol a reservoir for α-tocopheryl hydroquinone? Free Rad Biol Med 19:197-207.
35. Kovacic P, Jacintho JD. 2001. Mechanisms of carcinogenesis: Focus on oxidative stress and electron transfer. Curr Med Chem 8:773-796.
36. Kovvald A. 2001. The mitochondrial theory of aging. Biol Signals Recept 10:162-175.
37. Kremer ML. 1999. Mechanism of the Fenton reaction. Evidence for a new intermediate. Phys Chem Chem Phys 1:3595-3605.
38. Lehucker-Michel MP, Lesgards JF, Delubac O, Stocker P, Durand P, Prost M. 2001. Oxidative stress and human disease: current knowledge and perspectives for prevention. Presse Med 30: 1076-1081.
39. Leuwen A, Sugawara T, Gasche Y, Fujimura M, Chan PH. 2001. Oxidative cellular damage and the reduction of APE/Ref-1 expression after traumatic brain injury. Neurobiol Dis 8:380-390.
40. Liehr JG, Roy D. 1990. Free radical generation by redox cycling of estrogen. Free Rad Biol Med 8:415-432.
41. Liehr JG, Fang WF, Sirbasku DA, Ariulubelen A. 1986a. Carcinogenicity of catechol estrogens in Syrian hamsters. J Steroid Biochem Mol Biol 24:353-356.
42. Liehr JG, Uluben AA, Strobel HW. 1986b. Cytochrome P-450-mediated redox cycling of estrogens. J Biol Chem 261:16865-16870.
43. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. 1999. Increased DNA oxidation and decreased levels of repaire products in Alzheimer's disease ventricular CSF. J Neurochem 72:771-776.
44. Lucarini M, Pedrelli P, Peduli GF, Cabiddu S, Fattuoni C. 1996. Bond dissociation energies of O-H bonds in substituted phenols from equilibration studies. J Org Chem 61:9259-9263.
45. MacLusky NJ, Naftolin F, Krey LC, Franks S. 1981. The catechol estrogens. J Steroid Biochem Mol Biol 15:111-124.
46. McCann SM, Licinio J, Wong ML, Yu WH, Karanth S, Rettorri V 1998. The nitric oxide hypothesis of aging. Exp Gerontol 33:813-826.
47. McCay PB, Brueggemann G, Lai EK, Powell SR. 1989. Evidence that alpha-tocopherol functions cyclically to quench free radicals in hepatic microsomes. Ann NY Acad Sci 570:32-45.
48. Minotti G, Aust SD. 1987. The role of iron in the initiation of lipid peroxidation. Chem Phys Lipids 44:191-208.
49. Miranda S, Opazo C, Larrondo LF, Munoz FJ, Ruiz F, Leighton F, Inestrosa N. 2000. The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer's disease. Prog Neurobiol 62:633-648.
50. Mooradian AD. 1993. Antioxidant properties of steroids. J Steroid Biochem Mol Biol 45:509-511.
51. Moore AN, Ingold KU. 1997. α-Tocopherol quinone is converted into vitamin E in man. Free Rad Biol Med 22:931-934.
52. Moosmann B, Behl C. 1999. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc Natl Acad Sci USA 96:8867-8872.
53. Moslen MT, Smith CV. 1992. Free radical mechanisms of tissue injury. Boca Raton: CRC Press.
54. Naiki H, Hasegawa K, Yamaguchi I, Nakamura H, Gejyo F, Nakakuki K. 1998. Apolipoprotein E and antioxidants have different mechanism of inhibiting Alzheimer's β-amyloid fibril formation in vitro. Biochemistry 37:17882-17889.
55. Neuzil J, Witting PK, Stocker R. 1997. α-Tocopheryl hydroquinone is an efficient multifunctional inhibitor of radical-initiated oxidation of low density lipoprotein lipids. Proc Natl Acad Sci USA 94:7885-7890.
56. Newbold RR, Liehr JG. 2000. Induction of uterine carcinoma in CD-1 mice by catechol estrogens. Cancer Res 60:235-237.
57. Nisker JA, Hammond GL, Davidson BJ, Frumar AM, Takaki NK, Judd HL, Siiteri PK. 1980. Serum sex hormone-binding globulin capacity and the percentage of free estradiol in post-menopausal women with and without endometrial carcinoma: a new biochemical basis for the association between obesity and endometrial carcinoma. Am J Obstet Gynecol 138:637-642.
58. Ortiz GG, Sanchez-Ruiz MY, Tan DX, Reiter RJ, Benitz-King G, Beas-Zarate C. 2001. Melatonin, vitamin E, and estrogen reduce damage induced by kainic acid in the hippocampus: potassium-stimulated GABA release. J Pineal Res 31:62-67.
59. Packer JE, Slater TF, Wilson RL. 1979. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 278:737-738.
60. Patel RP, McAndrew J, Sellak H, White CR, Jo HJ, Freeman BA, Darley-Usmar VM. 1999. Biological aspects of reactive nitrogen species. Biochim Biophys Acta 1411:385-400.
61. Pedulli GF, Lucarini A, Pedrielli P 1997. Bond dissociation energies of phenolic and amine antioxidants. In: Minisci F, editor. Free radicals in biology and environment. Dordrecht: Kluwer Academic Publishers. p 169-180.
62. Perez EJ, Cai ZY, Covey DF, Simpkins JW. 2006. Neuroprotective effects of estratriene analogs: structure-activity relationships and molecular optimization. Drug Dev Res 66:78-92 (this issue).
63. Pezzella A, Lista L, Napolitano A, d'Ischia M. 2004. Oxidative coupling of 17β-estradiol: inventory of oligomer products and configuration assignment of atropoisomeric C4-linked biphenyl-type dimers and trimers. J Org Chem 69:5652-5659.
64. Picazo O, Azcoitia I, Garcia-Segura LM. 2003. Neuroprotective and neurotoxic effects of estrogens. Brain Res 990:20-27.
65. Pinero JD, Connor JR. 2000. Iron in the brain: An important contributor in normal and diseased states. Neuroscientist 6: 435-452.
66. Prokai L, Oon SM, Prokai-Tatrai K, Abboud KA, Simpkins JW. 2001. Synthesis and biological evaluation of 17β-alkoxyestra-1,3,5(10)-trienes as potential neuroprotectants against oxidative stress. J Med Chem 44:110-114.
67. Prokai L, Prokai-Tatrai K, Perjesi P, Zharikova AD, Perez EJ, Liu R, Simpkins JW. 2003a. Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc Natl Acad Sci USA 100: 11741-11746.
68. Prokai L, Prokai-Tatrai K, Perjesi P, Zharikova AD, Simpkins JW. 2003b. Quinol-based bioreversible metabolic cycle for estrogens in rat liver microsomes. Drug Metab Disp 31:701-704.
69. 8,9-dehydro derivatives of 17 estradiol and 17 estradiol. Steroids 62:304-310.
70. Ruiz-Larrea B, Leal A, Martin C, Martinez R, Lacort M. 1995. Effects of estrogens on the redox chemistry of iron: a possible mechanism of the antioxidant action of estrogens. Steroids 60:780-783.
71. Ruiz-Larrea MB, Martin C, Martinez R, Navarro R, Lacort M. Miller NJ. 2000. Antioxidant activities of estrogens against aqueous and lipophilic radicals; differences between phenol and catechol estrogens. Chem Phys Lipids 105:179-188.
72. Simpkins JW, Wang J, Wang X, Perez EJ, Prokai L, Dykens JA. 2005. Mitochondria play a central role in estrogen-induced neuroprotection. Curr Drug Targets 4:69-83.
73. Sinkula AA, Yalkowsky SH. 1975. Rationale for design of biologically reversible drug derivatives: Prodrugs. J Pharm Sci 64: 181-210.
74. Smith MA, Hirai K, Hsiao K, Pappolla MA, Harris PL, Siedlak SL, Tabaton M, Perry G. 1998. Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 70:2212-2215.
75. Sohal RS. 2002. Role of oxidative stress and protein oxidation in the aging process. Free Rad Biol Med 33:37-44.
76. Speir E, Yu Z-X, Takeda K, Ferrans VJ, Cannon RO. 2000. Antioxidant effect of estrogen on cytomegalovirus-induced gene expression in coronary artery smooth muscle cells. Circulation 102:2990-2996.
77. Stella VJ, Charman WNA, Naringrekar VH. 1985. Prodrugs. Do they have advantages in clinical practice? Drugs 29:455-473.
78. Van Haaften RIM, Evelo CTA, Haenen GRMM, Bast A. 2001. No reduction of α-tocopherol quinone by glutathione in rat liver microsomes. Biochem Pharmacol 61:715-719.
79. Varadarajan S, Yatin S, Aksenova M, Butterfield DA. 2000. Review: Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol 130:184-208.
80. Vedder H, Anthens N, Stumm G, Wurz C, Behl C, Krieg JC. 1999. Estrogen hormones reduce lipid peroxidation in cells and tissues of the central nervous system. J Neurochem 72: 2531-2538.
81. Victor VV, Guayerbas N, Puerto M, Medina S, De-la-Fuente M. 2000. Ascorbic acid modulates in vitro the function of macrophages from mice with endotoxic shock. Immunopharmacology 46:89-101.
82. Vihtamaki T, Parantainen J, Kolvisto AM, Metsa-Ketela T, Tuimala R. 2002. Oral ascorbic acid increases plasma oestradiol during postmenopausal hormone replacement therapy. Maturitas 42: 129-135.
83. Wallace DC. 2001. A mitochondrial paradigm for degenerative diseases and ageing. Novartis Found Symp 235:247-263.
84. Walling C. 1975. Fenton's reagent revisited. Acc Chem Res 28: 125-131.
85. Winterle JS, Mill T, Harris T, Goldbeck RA. 2001. Absolute kinetic characterization of 17-β-estradiol as a radical-scavenging, antioxidant Synergist. Arch Biochem Biophys 392:233-244.
86. Wright JS, Johnson ER, DiLabio GA. 2001. Predicting the activity of phenolic antioxidants: Theoretical method, analysis of substitutent effects and application to major families of antioxidants. J Am Chem Soc 123:1173-1183.
87. Wu S, Tamaki N, Nagashima T, Yamaguchi M. 1998. Reactive oxygen species in reoxygenation injury of rat brain capillary endothelial cells. Neurosurgery 43:577-583.
88. Young IS, Woodside JV. 2001. Antioxidants in health and disease. J Clin Pathol 54:176-186.